免疫抑制治疗再生障碍性贫血的选择

[1]	Killick SB,Bown N,Cavenagh J,et al.Guidelines for the diagnosis and management of adult aplastic anaemia[J].Br J Haematol,2016,172,187-207.
[2]	何广胜.再生障碍性贫血:免疫抑制治疗存在的问题及对策[J].临床血液学杂志,2014,27(3):195-198.
[3]	中华医学会血液学分会红细胞疾病组.再生障碍性贫血诊断治疗专家共识[J].中华血液学杂志,2010,31(11):790-792.
[4]	Yagasaki H,Shichino H,Ohara A,et al.Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children[J].Ann Hematol,2014,93:747-752.
[5]	Scheinberg P,Cooper JN,Sloand EM,et al.Association of telomere length of peripheral blood leukocytes with hematopoietic relapse,malignant transformation,and survival in severe aplastic anemia[J].JAMA,2010,304:1358-1364.
[6]	Takamatsu H,Yagasaki H,Takahashi Y,et al.Aplastic anemia successfully treated with rituximab:the possible role of aplastic anemia-associated antibody as a marker for response[J].Eur J Haematol,2011,86:541-545.
[7]	Marsh JC,Ball SE,Darbyshire P,et al.Guidelines for the diagnosis and management of aplastic anaemia[J].Br J Haematol,2003,123:782-801.
[8]	Marsh JC,Ball SE,Cavenagh J,et al.Guidelines for the diagnosis and management of aplastic anaemia[J].Br J Haematol,2009,147:43-70.
[9]	Dufour C,Svahn J,Bacigalupo A,et al.Front-line immunosuppressive treatment of acquired aplastic anemia[J].Bone Marrow Transplant,2013,48:174-177.
[10]	Marsh JC,Bacigalupo A,Schrezenmeier H,et al.Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anemia Working Party[J].Blood,2012,119:5391-5396.
[11]	Scheinberg P,Nunez O,Wu C,et al.Treatment of severe aplastic anaemia with combined immunosuppression:anti-thymocyte globulin,ciclosporin and mycophenolate mofetil[J].Br J Haematol,2006,133:606-611.
[12]	Scheinberg P,Wu CO,Nunez O,et al.Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine,with or without sirolimus:a prospective randomized study[J].Haematologica,2009,94:348-354.
[13]	Scheinberg P,Nunez O,Weinstein B,et al.Activity of alemtuzumab monotherapy in treatment-naive,relapsed,and refractory severe acquired aplastic anemia[J].Blood,2012,119:345-354.
[14]	Bacigalupo A,Socié G,Hamladji RM,et al.Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia:an EBMT analysis[J].Haematologica,2015,100:696-702.